Health utilities of type 2 diabetes-related complications: A cross-sectional study in Sweden

International Journal of Environmental Research and Public Health

Volumn 11, Issue 5, 2014, Pages 4939-4952

  Kiadaliri, Aliasghar A ^a,b,c   Gerdtham, Ulf G ^a,c,d   Eliasson, Björn ^e   Gudbjörnsdottir, Soffia ^e   Svensson, Ann Marie ^e   Carlsson, Katarina Steen ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

EQ 5D; Health utility; Sweden; Type 2 diabetes

Indexed keywords

CARDIOVASCULAR DISEASE; COST-BENEFIT ANALYSIS; DECISION MAKING; DIABETES; HEALTH CARE; HEALTH SERVICES; STROKE; TARIFF STRUCTURE;

ADULT; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST UTILITY ANALYSIS; DATA ANALYSIS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; SEX DIFFERENCE; SWEDEN; SYNDROME DELINEATION; VASCULAR DISEASE; VERY ELDERLY; YOUNG ADULT; COMPLICATION; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ECONOMICS; EPIDEMIOLOGY; HEALTH SERVICE; HEALTH STATUS; MIDDLE AGED; QUESTIONNAIRE; TIME; UTILIZATION;

SWEDEN;

ADULT; AGED; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SERVICES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; SWEDEN; TIME FACTORS;

EID: 84900520904     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110504939     Document Type: Article

References (44)

1. Whiting, D.R.; Guariguata, L.; Weil, C.; Shaw, J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94, 311-321.
2. Cheng, D. Prevalence, predisposition and prevention of type II diabetes. Nutr. Metab. (Lond.) 2005, 2, 29, doi:10.1186/1743-7075-2-29.
3. Booth, G.L.; Kapral, M.K.; Fung, K.; Tu, J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study. Lancet 2006, 368, 29-36.
4. Coresh, J.; Astor, B.C.; Greene, T.; Eknoyan, G.; Levey, A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult us population: Third national health and nutrition examination survey. Am. J. Kidney Dis. 2003, 41, 1-12.
5. Sarwar, N.; Gao, P.; Seshasai, S.R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D.A.; Selvin, E.; Stampfer, M.; et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215-2222.
6. Fox, C.S.; Pencina, M.J.; Wilson, P.W.; Paynter, N.P.; Vasan, R.S.; D'Agostino, R.B., Sr. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the framingham heart study. Diabetes care 2008, 31, 1582-1584.
7. Ahmad Kiadaliri, A.; Gerdtham, U.G.; Nilsson, P.; Eliasson, B.; Gudbjornsdottir, S.; Carlsson, K.S. Towards renewed health economic simulation of type 2 diabetes: Risk equations for first and second cardiovascular events from swedish register data. PloS One 2013, 8, e62650, doi:10.1371/journal.pone.0062650.
8. Mulnier, H.E.; Seaman, H.E.; Raleigh, V.S.; Soedamah-Muthu, S.S.; Colhoun, H.M.; Lawrenson, R.A. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006, 23, 516-521.
9. Gu, K.; Cowie, C.C.; Harris, M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998, 21, 1138-1145.
10. Grandy, S.; Fox, K.M. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the shield longitudinal study. Health Qual. Life Outcomes 2012, 10, 99, doi:10.1186/1477-7525-10-99.
11. Al-Shehri, A.H.; Taha, A.Z.; Bahnassy, A.A.; Salah, M. Health-related quality of life in type 2 diabetic patients. Ann. Saudi. Med. 2008, 28, 352-360.
12. Kiadaliri, A.A.; Najafi, B.; Mirmalek-Sani, M. Quality of life in people with diabetes: A systematic review of studies in Iran. J. Diabetes Metab. Disord. 2013, 12, 54, doi:10.1186/2251-6581-12-54.
13. Oliva, J.; Fernandez-Bolanos, A.; Hidalgo, A. Health-related quality of life in diabetic people with different vascular risk. BMC Public Health 2012, 12, 812, doi:10.1186/1471-2458-12-812.
14. Zhang, P.; Brown, M.B.; Bilik, D.; Ackermann, R.T.; Li, R.; Herman, W.H. Health utility scores for people with type 2 diabetes in U.S. Managed care health plans: Results from translating research into action for diabetes (triad). Diabetes Care 2012, 35, 2250-2256.
15. O'Reilly, D.J.; Xie, F.; Pullenayegum, E.; Gerstein, H.C.; Greb, J.; Blackhouse, G.K.; Tarride, J.E.; Bowen, J.; Goeree, R.A. Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Qual. Life Res 2011, 20, 939-943.
16. Bagust, A.; Beale, S. Modelling euroqol health-related utility values for diabetic complications from code-2 data. Health Econ. 2005, 14, 217-230.
17. Clarke, P.; Gray, A.; Holman, R., Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med. Decis. Making 2002, 22, 340-349.
18. Ragnarson Tennvall, G.; Apelqvist, J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J. Diabetes Complications 2000, 14, 235-241.
19. Ekstrom, W.; Al-Ani, A.N.; Saaf, M.; Cederholm, T.; Ponzer, S.; Hedstrom, M. Health related quality of life, reoperation rate and function in patients with diabetes mellitus and hip fracture-A 2 year follow-up study. Injury 2013, 44, 769-775.
20. Hanberger, L.; Ludvigsson, J.; Nordfeldt, S. Health-related quality of life in intensively treated young patients with type 1 diabetes. Pediatr. Diabetes 2009, 10, 374-381.
21. Wandell, P.E.; Tovi, J. The quality of life of elderly diabetic patients. J. Diabetes Complications 2000, 14, 25-30.
22. Wandell, P.E.; Brorsson, B.; Aberg, H. Quality of life among diabetic patients in Swedish primary health care and in the general population: Comparison between 1992 and 1995. Qual. Life Res. 1998, 7, 751-760.
23. Dolan, P.; Gudex, C.; Kind, P.; Williams, A. The time trade-off method: Results from a general population study. Health Econ. 1996, 5, 141-154.
24. Burstrom, K.; Sun, S.; Gerdtham, U.G.; Henriksson, M.; Johannesson, M.; Levin, L.A.; Zethraeus, N. Swedish experience-based value sets for EQ-5D health states. Qual. Life Res. 2014, 23, 431-442.
25. Gudbjornsdottir, S.; Cederholm, J.; Nilsson, P.M.; Eliasson, B. The national diabetes register in sweden: An implementation of the St. Vincent declaration for quality improvement in diabetes care. Diabetes care 2003, 26, 1270-1276.
26. Brooks, R. Euroqol: The current state of play. Health Policy 1996, 37, 53-72.
27. Li, L.; Fu, A. Some methodological issues with the analysis of preference-based EQ-5D index score. Health Serv. Outcomes Res. Method. 2009, 9, 162-176.
28. Huang, I.C.; Frangakis, C.; Atkinson, M.J.; Willke, R.J.; Leite, W.L.; Vogel, W.B.; Wu, A.W. Addressing ceiling effects in health status measures: A comparison of techniques applied to measures for people with HIV disease. Health Serv. Res. 2008, 43, 327-339.
29. Pullenayegum, E.M.; Tarride, J.E.; Xie, F.; Goeree, R.; Gerstein, H.C.; O'Reilly, D. Analysis of health utility data when some subjects attain the upper bound of 1: Are tobit and clad models appropriate? Value Health 2010, 13, 487-494.
30. Shmueli, A. Reporting heterogeneity in the measurement of health and health-related quality of life. Pharmaco. Economics 2002, 20, 405-412.
31. Jylha, M.; Guralnik, J.M.; Ferrucci, L.; Jokela, J.; Heikkinen, E. Is self-rated health comparable across cultures and genders? J. Gerontol. B Psychol. Sci. Soc. Sci. 1998, 53, S144-S152.
32. Bonsergent, E.; Benie-Bi, J.; Baumann, C.; Agrinier, N.; Tessier, S.; Thilly, N.; Briancon, S. Effect of gender on the association between weight status and health-related quality of life in adolescents. BMC Public Health 2012, 12, 997, doi:10.1186/1471-2458-12-997.
33. Ara R. Health Related Quality of Life by Age, Gender and History of Cardiovascular Disease: Results from the Health Survey for England; Health Economics and Decision Science, University of Sheffield: Sheffield, UK, 2009.
34. Hunger, M.; Schunk, M.; Meisinger, C.; Peters, A.; Holle, R. Estimation of the relationship between body mass index and EQ-5D health utilities in individuals with type 2 diabetes: Evidence from the population-based kora studies. J. Diabetes Complications 2012, 26, 413-418.
35. Solli, O.; Stavem, K.; Kristiansen, I.S. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual. Life Outcomes 2010, 8, 18, doi:10.1186/1477-7525-8-18.
36. Burstrom, K.; Johannesson, M.; Diderichsen, F. Swedish population health-related quality of life results using the EQ-5D. Qual. Life Res. 2001, 10, 621-635.
37. Boyd, N.F.; Sutherland, H.J.; Heasman, K.Z.; Tritchler, D.L.; Cummings, B.J. Whose utilities for decision analysis? Med. Decis. Making 1990, 10, 58-67.
38. De Wit, G.A.; Busschbach, J.J.; De Charro, F.T. Sensitivity and perspective in the valuation of health status: Whose values count? Health Econ. 2000, 9, 109-126.
39. Ubel, P.A.; Loewenstein, G.; Jepson, C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual. Life Res. 2003, 12, 599-607.
40. Rand-Hendriksen, K.; Augestad, L.A.; Kristiansen, I.S.; Stavem, K. Comparison of hypothetical and experienced EQ-5D valuations: Relative weights of the five dimensions. Qual. Life Res. 2012, 21, 1005-1012.
41. Norman, R.; Cronin, P.; Viney, R.; King, M.; Street, D.; Ratcliffe, J. International comparisons in valuing EQ-5D health states: A review and analysis. Value Health 2009, 12, 1194-1200.
42. Sakamaki, H.; Ikeda, S.; Ikegami, N.; Uchigata, Y.; Iwamoto, Y.; Origasa, H.; Otani, T.; Otani, Y. Measurement of hrql using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health 2006, 9, 47-53.
43. Kontodimopoulos, N.; Pappa, E.; Chadjiapostolou, Z.; Arvanitaki, E.; Papadopoulos, A.A.; Niakas, D. Comparing the sensitivity of EQ-5D, SF-6D AND 15D utilities to the specific effect of diabetic complications. Eur. J. Health Econ. 2012, 13, 111-120.
44. Luscombe, F.A. Health-related quality of life measurement in type 2 diabetes. Value Health 2000, 3 (Suppl. 1), 15-28.